• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Torsades de pointes ventricular tachycardia and terodiline.

作者信息

Connolly M J, Astridge P S, White E G, Morley C A, Cowan J C

机构信息

Department of Geriatric Medicine, St Luke's Hospital, Bradford, UK.

出版信息

Lancet. 1991 Aug 10;338(8763):344-5. doi: 10.1016/0140-6736(91)90481-4.

DOI:10.1016/0140-6736(91)90481-4
PMID:1677700
Abstract

We report five patients (four women, one man; mean age 74 years, range 55-87) taking terodiline who had torsades de pointes ventricular tachycardia associated with prolongation of the QT interval. The QT interval was normal before the introduction of terodiline in three patients and returned to normal after terodiline withdrawal in four. Atrioventricular conduction disturbance or bradycardia were evident in all patients. Terodiline should be prescribed with caution to elderly patients.

摘要

相似文献

1
Torsades de pointes ventricular tachycardia and terodiline.
Lancet. 1991 Aug 10;338(8763):344-5. doi: 10.1016/0140-6736(91)90481-4.
2
[Torsades de pointes ventricular tachycardia caused by terodiline (Mictrol)?].[特罗地林（Mictrol）引起的尖端扭转型室性心动过速？]
Ugeskr Laeger. 1992 Sep 28;154(40):2760-1.
3
[Polymorph ventricular tachycardia with torsades de pointes caused by administration of terodiline (Mictrol)].
Ned Tijdschr Geneeskd. 1992 Jan 11;136(2):91-3.
4
[Polymorph ventricular tachycardia with torsades de pointes in administration of terodiline (Mictrol)].
Ned Tijdschr Geneeskd. 1992 Mar 14;136(11):542-3.
5
Torsades de pointes and terodiline.
Lancet. 1991 Sep 7;338(8767):632-3.
6
Terodiline and torsades de pointes.特罗地林与尖端扭转型室性心动过速
BMJ. 1991 Aug 31;303(6801):519-20.
7
Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence.替地定在治疗尿失禁患者中浓度依赖性的心脏毒性。
Br Heart J. 1995 Jul;74(1):53-6. doi: 10.1136/hrt.74.1.53.
8
CYP2D6 and CYP2C19 genotypes of patients with terodiline cardiotoxicity identified through the yellow card system.通过黄卡系统识别出的特罗地林心脏毒性患者的CYP2D6和CYP2C19基因型。
Br J Clin Pharmacol. 2000 Jul;50(1):77-80. doi: 10.1046/j.1365-2125.2000.00230.x.
9
[Torsades de pointes heart arrhythmia caused by terodiline].
Tidsskr Nor Laegeforen. 1992 Jan 20;112(2):197-8.
10
Terodiline causes polymorphic ventricular tachycardia due to reduced heart rate and prolongation of QT interval.特罗地林因心率降低和QT间期延长而导致多形性室性心动过速。
Eur J Clin Pharmacol. 1992;42(6):577-80. doi: 10.1007/BF00265918.

引用本文的文献

1
Torsade de pointes associated with the combination of solifenacin and clenbuterol for urinary incontinence.与索利那新和克仑特罗联合使用治疗尿失禁相关的尖端扭转型室性心动过速。
J Cardiol Cases. 2013 Dec 12;9(3):91-93. doi: 10.1016/j.jccase.2013.10.009. eCollection 2014 Mar.
2
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics.发表药品不良反应病例报告的重要性：促进公众健康并推动药理学与治疗学发展
Drug Saf Case Rep. 2017 Sep 20;4(1):11. doi: 10.1007/s40800-017-0053-0.
3
Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.
老年患者药物性尖端扭转型室速中QT间期延长剂的鲁莽使用。
Z Gerontol Geriatr. 2018 Jan;51(1):41-47. doi: 10.1007/s00391-016-1155-5. Epub 2016 Nov 22.
4
QT prolongation and torsade de pointes associated with solifenacin in an 81-year-old woman.一名81岁女性使用索利那新后出现QT间期延长及尖端扭转型室性心动过速
Br J Clin Pharmacol. 2008 Dec;66(6):896-7. doi: 10.1111/j.1365-2125.2008.03298.x.
5
Electrophysiological profile of propiverine--relationship to cardiac risk.丙哌维林的电生理特征——与心脏风险的关系
Naunyn Schmiedebergs Arch Pharmacol. 2008 Feb;376(6):431-40. doi: 10.1007/s00210-007-0231-1. Epub 2007 Dec 19.
6
The Q-T interval and antimuscarinic drugs.Q-T间期与抗胆碱能药物。
Curr Urol Rep. 2005 Nov;6(6):405-9. doi: 10.1007/s11934-005-0033-2.
7
Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.药物诱导的尖端扭转型室性心动过速的药物遗传学方面：改善临床药物开发和处方的潜在工具。
Drug Saf. 2004;27(3):145-72. doi: 10.2165/00002018-200427030-00001.
8
Differences in the effects of urinary incontinence agents S-oxybutynin and terodiline on cardiac K(+) currents and action potentials.尿失禁药物S-奥昔布宁和特罗地林对心脏钾离子电流及动作电位影响的差异
Br J Pharmacol. 2000 Sep;131(2):245-54. doi: 10.1038/sj.bjp.0703595.
9
CYP2D6 and CYP2C19 genotypes of patients with terodiline cardiotoxicity identified through the yellow card system.通过黄卡系统识别出的特罗地林心脏毒性患者的CYP2D6和CYP2C19基因型。
Br J Clin Pharmacol. 2000 Jul;50(1):77-80. doi: 10.1046/j.1365-2125.2000.00230.x.
10
Block and modified gating of cardiac calcium channel currents by terodiline.特罗地林对心脏钙通道电流的阻断及改良门控作用
Br J Pharmacol. 1999 Aug;127(8):1837-45. doi: 10.1038/sj.bjp.0702713.